Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated diurnal CD36 expression disrupts the bile acid synthesis rhythm leading to cholestatic liver injury and inflammation via the HMGCR/CYP7A1 axis.

Genes & diseases·2026
Same author

Ligand-Activated Fluorescent Probe Reveals Mitochondrial Long-Chain Saturated Fatty Acid Flux: An Effective Tool for Metabolic Disorder Studies.

Small methods·2026
Same author

Hypoxia-responsive modules via tunable hydrophobicity reversal enhance renal-targeted release of CD36-interfering nanoparticles to ameliorate acute kidney injury.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Dietary monounsaturated fatty acid facilitates lipid droplet turnover through chaperone HSP90A-mediated lysosomal degradation of PLIN2 in hepatocellular carcinoma.

Autophagy·2025
Same author

The X-Age Project to construct a Chinese aging clock.

Nature aging·2025
Same author

SCAP Interacts with Trim27 to Promote Vascular Neointimal Hyperplasia by Regulating the Stability and Ubiquitination of IκBα.

Aging and disease·2025

Related Experiment Video

Updated: Jun 19, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

An update on the lipid nephrotoxicity hypothesis.

Xiong Z Ruan1, Zac Varghese, John F Moorhead

  • 1Centre for Nephrology, University College London Medical School, Royal Free Campus, London, UK. x.ruan@medsch.ucl.ac.uk

Nature Reviews. Nephrology
|October 28, 2009
PubMed
Summary

Lipid abnormalities and chronic kidney disease (CKD) create a cycle of self-perpetuating renal damage. Inflammatory stress in CKD alters lipid metabolism, leading to cholesterol accumulation and potential statin resistance.

Related Experiment Videos

Last Updated: Jun 19, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Lipid Metabolism

Background:

  • The lipid nephrotoxicity hypothesis (1982) proposed that hyperlipidemia and proteinuria cause self-perpetuating renal disease.
  • Growing evidence links lipid abnormalities to both atherosclerosis and glomerulosclerosis.
  • Understanding the interplay between lipids and kidney disease is crucial for managing cardiovascular risk.

Purpose of the Study:

  • To review research developments supporting the lipid nephrotoxicity hypothesis.
  • To elucidate how chronic kidney disease-associated inflammation alters lipid homeostasis.
  • To discuss the implications for understanding lipid-mediated injury and treatment.

Main Methods:

  • Review of existing research on lipid metabolism in chronic kidney disease.
  • Analysis of inflammatory stress effects on cellular cholesterol transport and synthesis.
  • Examination of cholesterol redistribution and accumulation in various tissues.

Main Results:

  • Inflammatory stress in CKD increases cholesterol uptake and impairs efflux and synthesis.
  • Cholesterol accumulates in renal, vascular, and hepatic tissues, causing injury.
  • Inflammatory stress may lead to statin resistance through unknown mechanisms.

Conclusions:

  • Lipid nephrotoxicity is a significant factor in the progression of renal and vascular disease.
  • Altered lipid homeostasis in CKD impacts tissue injury and plasma cholesterol levels.
  • Findings may necessitate re-evaluation of cardiovascular risk assessment and lipid-lowering therapy in CKD patients.